ES2009547A6 - Un procedimiento para la preparacion de nuevos tetrazoles - Google Patents

Un procedimiento para la preparacion de nuevos tetrazoles

Info

Publication number
ES2009547A6
ES2009547A6 ES8800533A ES8800533A ES2009547A6 ES 2009547 A6 ES2009547 A6 ES 2009547A6 ES 8800533 A ES8800533 A ES 8800533A ES 8800533 A ES8800533 A ES 8800533A ES 2009547 A6 ES2009547 A6 ES 2009547A6
Authority
ES
Spain
Prior art keywords
preparation
alkyl
intermediates
hydrogen
tetrazole compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8800533A
Other languages
English (en)
Spanish (es)
Inventor
John J Wright
Sing-Yuen Sit
Neelakantan Balasubramanian
Peter J Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES2009547A6 publication Critical patent/ES2009547A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES8800533A 1987-02-25 1988-02-24 Un procedimiento para la preparacion de nuevos tetrazoles Expired ES2009547A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1855887A 1987-02-25 1987-02-25
US07/151,512 US4898949A (en) 1987-02-25 1988-02-18 Intermediates for the preparation of antihypercholesterolemic tetrazole compounds

Publications (1)

Publication Number Publication Date
ES2009547A6 true ES2009547A6 (es) 1989-10-01

Family

ID=26691250

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8800533A Expired ES2009547A6 (es) 1987-02-25 1988-02-24 Un procedimiento para la preparacion de nuevos tetrazoles

Country Status (27)

Country Link
US (1) US4898949A (en:Method)
JP (1) JP2603284B2 (en:Method)
KR (1) KR960007167B1 (en:Method)
CN (1) CN1030077C (en:Method)
AT (1) AT395588B (en:Method)
AU (1) AU610562B2 (en:Method)
BE (1) BE1002115A3 (en:Method)
CA (1) CA1328269C (en:Method)
CH (1) CH678182A5 (en:Method)
DE (1) DE3805789C2 (en:Method)
DK (2) DK97388A (en:Method)
ES (1) ES2009547A6 (en:Method)
FI (1) FI96600C (en:Method)
FR (1) FR2611201B1 (en:Method)
GB (1) GB2202845B (en:Method)
GR (1) GR1000473B (en:Method)
HU (3) HU201533B (en:Method)
IE (1) IE61608B1 (en:Method)
IT (1) IT1216752B (en:Method)
LU (1) LU87143A1 (en:Method)
MY (1) MY102290A (en:Method)
NL (1) NL8800468A (en:Method)
NO (1) NO178432C (en:Method)
NZ (1) NZ223621A (en:Method)
PT (1) PT86821B (en:Method)
SE (3) SE504553C2 (en:Method)
YU (1) YU46781B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5260325A (en) * 1991-08-19 1993-11-09 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking tertiary amides
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
AU755543B2 (en) * 1997-12-19 2002-12-12 Warner-Lambert Export Limited Process for the synthesis of 1,3-diols

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
NZ194557A (en) * 1979-08-17 1984-09-28 Merck & Co Inc Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
WO1984002131A1 (fr) * 1982-11-22 1984-06-07 Sandoz Ag Produits analogues de mevalolactone et leurs derives, leurs procedes de production, compositions pharmaceutiques les contenant ainsi que leur utilisation en tant que produits pharmaceutiques
CA1268473A (en) * 1983-01-24 1990-05-01 Paul L. Anderson Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
FI860755A7 (fi) * 1984-06-22 1986-02-20 Sandoz Ag Mevalonolaktonin pyratsolianalogeja ja niiden johdannaisia, menetelmi ä niiden valmistamiseksi sekä niiden käyttö.
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
AU601264B2 (en) * 1987-02-25 1990-09-06 Bristol-Myers Squibb Company Antihypercholesterolemic tetrazole compounds

Also Published As

Publication number Publication date
LU87143A1 (fr) 1988-09-20
GR880100100A (en) 1988-12-16
BE1002115A3 (fr) 1990-07-10
GB2202845B (en) 1991-05-22
KR960007167B1 (ko) 1996-05-29
FI96600B (fi) 1996-04-15
KR880009946A (ko) 1988-10-06
SE8800637L (sv) 1988-08-26
NO178432C (no) 1996-03-27
CA1328269C (en) 1994-04-05
DK113897A (da) 1997-10-06
NL8800468A (nl) 1988-09-16
CN1030077C (zh) 1995-10-18
CN1070642A (zh) 1993-04-07
MY102290A (en) 1992-05-15
GB8804281D0 (en) 1988-03-23
FI880868A0 (fi) 1988-02-24
DE3805789A1 (de) 1988-09-15
SE8800637D0 (sv) 1988-02-24
AT395588B (de) 1993-01-25
JPS63290872A (ja) 1988-11-28
DK97388D0 (da) 1988-02-24
IE61608B1 (en) 1994-11-16
HUT47258A (en) 1989-02-28
YU46781B (sh) 1994-05-10
SE504553C2 (sv) 1997-03-03
US4898949A (en) 1990-02-06
IT1216752B (it) 1990-03-08
DE3805789C2 (de) 2001-05-31
AU1213288A (en) 1988-09-01
DK97388A (da) 1988-08-26
SE9300976L (en:Method) 1993-03-24
PT86821A (pt) 1988-03-01
NO880802D0 (no) 1988-02-24
GB2202845A (en) 1988-10-05
HU201533B (en) 1990-11-28
NO880802L (no) 1988-08-26
SE9300976D0 (sv) 1993-03-24
SE512485C2 (sv) 2000-03-20
HU201532B (en) 1990-11-28
NO178432B (no) 1995-12-18
HU895124D0 (en:Method) 1990-01-28
FR2611201A1 (fr) 1988-08-26
FR2611201B1 (fr) 1991-01-11
FI880868A7 (fi) 1988-08-26
IT8819526A0 (it) 1988-02-24
YU36488A (en) 1990-02-28
HU201534B (en) 1990-11-28
FI96600C (fi) 1996-07-25
NZ223621A (en) 1991-06-25
CH678182A5 (en:Method) 1991-08-15
PT86821B (pt) 1992-05-29
JP2603284B2 (ja) 1997-04-23
IE880502L (en) 1988-08-18
ATA46088A (de) 1992-06-15
SE503201C2 (sv) 1996-04-15
SE9300977L (en:Method)
GR1000473B (el) 1992-07-30
AU610562B2 (en) 1991-05-23
SE9300977D0 (sv) 1993-03-24

Similar Documents

Publication Publication Date Title
MY101284A (en) Tetrazole intermediates to antihypertensive compounds
GB9203347D0 (en) Hypolipidaemic compounds
ATE195938T1 (de) 2-(1',2',4'-triazol-3'yloxymethylen)-anilide und ihre verwendung als schädlingsbekämpfungsmittel
ES481549A1 (es) Un procedimiento para la producicion de un derivado de feni-letanolamina.
DK0562734T3 (da) Antitumorforbindelser indeholdende quinazolin- og tetrazolringe
EP0077938A3 (en) N-(3-substituted aminophenyl) tetrahydrophthalimides and herbicidal composition
FI73969B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva trans-4-aminometylcyklohexankarboxylsyraderivat.
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
MXPA02004440A (es) Derivados de pirrol como inhibidores de la fosfodiesterasa vii.
DE69131325D1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
DE69231445D1 (de) Triazole enthaltende antifungizide mittel
EP0244098A3 (en) Thiazolotriazole herbicides
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ATE46159T1 (de) Pyridazinone, inotrope mittel.
ES2009547A6 (es) Un procedimiento para la preparacion de nuevos tetrazoles
ES439889A1 (es) Un procedimiento para preparar nuevas tiadiazolilimidazoli- dinonas.
BG101601A (bg) Фармацевтични пиперазинови производни
EP0028936A3 (en) 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them
MY130817A (en) Herbicides
CA2337586A1 (en) Alkylation process and novel hydroxyphenylbenztriazoles
ES8502699A1 (es) Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas
GR81941B (en:Method)
BG106613A (en) Phenyl-and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
IL97289A0 (en) Tetraazaacenaphthylene-3-one derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20110222